News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
108 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (27903)
Month
January (3217)
February (3391)
March (3462)
April (3660)
May (4506)
June (2887)
July (2191)
August (2499)
September (2720)
October (3233)
November (3383)
December (2291)
Day
1 (138)
2 (86)
3 (59)
8 (97)
9 (101)
10 (84)
11 (105)
12 (56)
15 (90)
16 (125)
17 (106)
18 (118)
19 (57)
22 (108)
23 (101)
24 (100)
25 (139)
26 (75)
29 (161)
30 (126)
31 (159)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
8
9
10
11
12
15
16
17
18
19
22
23
24
25
26
29
30
31
Regulatory
GSK Plots Blenrep’s Path Back to Market With EU Filing
GSK is seeking to relaunch Blenrep after its market withdrawal in 2022. The pharma is eyeing a second-line niche for the antibody-drug conjugate in the treatment of relapsed or refractory multiple myeloma.
July 22, 2024
·
2 min read
·
Tristan Manalac
Regulatory
Lilly Wins Chinese Approval for Tirzepatide in Obesity on Heels of Novo’s Semaglutide
Eli Lilly’s tirzepatide, which has previously been approved in China for diabetes, can now also be used for chronic weight management in the world’s second most populated country.
July 22, 2024
·
2 min read
·
Tristan Manalac
Infectious disease
SIGA, US Government Ink $113M Procurement Deal for Smallpox, Mpox Drug
Oral doses of SIGA Technologies’ antiviral drug Tpoxx will help the U.S. maintain its reserves of the vaccine in preparation for future potential outbreaks, according to the company.
July 22, 2024
·
1 min read
·
Tristan Manalac
Press Releases
Assure Announces Extension of Exchange Offer Relating to its Convertible Notes
July 22, 2024
·
5 min read
Press Releases
SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer
July 22, 2024
·
3 min read
Press Releases
MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports
July 22, 2024
·
2 min read
Press Releases
Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024
July 22, 2024
·
3 min read
Press Releases
Oxford BioTherapeutics Named Best Tech SME of the Year at Thames Valley Tech & Innovation Awards 2024
July 22, 2024
·
3 min read
Press Releases
UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer
July 22, 2024
·
5 min read
Press Releases
DLH to Announce Fiscal 2024 Third Quarter Financial Results
July 22, 2024
·
1 min read
Previous
4 of 11
Next
